Quarterly ResultMay 6, 2026, 01:02 AM
Philips Q1 Comparable Sales +4% to EUR 3.9B; Adj. EBITA Margin 9.0%
AI Summary
Royal Philips reported a strong start to 2026, with Q1 comparable sales increasing 4% to EUR 3.9 billion and comparable order intake growing 6%. The company achieved a 40 basis point increase in its Adjusted EBITA margin, reaching 9.0%, and income from operations rose to EUR 241 million. Philips reiterated its full-year 2026 outlook and highlighted progress in its strategic pillars, including new AI-powered innovations and significant partnerships, alongside announcing a share repurchase program.
Key Highlights
- Comparable order intake grew 6% in Q1 2026.
- Group comparable sales increased 4% to EUR 3.9 billion.
- Adjusted EBITA margin rose 40 basis points to 9.0%.
- Income from operations increased to EUR 241 million.
- Personal Health comparable sales grew 9%, leading all segments.
- Free cash flow totaled EUR 28 million.
- Reiterated full-year 2026 outlook for sales and EBITA margin.
- Authorized repurchase of up to 4 million shares, valued at approximately EUR 91 million.